← Back to Longevity Research

Lifespan Podcast

Supplements, NAD Boosters & Longevity Drugs: What the Science Actually Says

Key Takeaways

1. NAD and the Biology of Aging

What NAD does. Nicotinamide adenine dinucleotide (NAD) is essential for energy production (ATP synthesis) and for activating sirtuins, the defensive enzymes Sinclair’s lab has studied for two decades. NAD is the second most abundant molecule in the body after ATP, and without it, death occurs within 30 seconds.

The age-related decline. NAD levels fall significantly with age due to both decreased synthesis and increased degradation. Even with optimal diet and exercise, individuals in the latter half of life have substantially lower NAD. This decline impairs sirtuin activation and the body’s ability to fight aging-related diseases.

Why supplements, not just lifestyle. While exercise and fasting both raise NAD, they cannot fully compensate for age-related decline. NAD boosters aim to restore youthful levels, effectively “prank-calling the Pentagon,” as Sinclair puts it, to mobilise the body’s defence systems against a threat that isn’t immediately present.

2. NR (Nicotinamide Riboside)

Mechanism. NR is vitamin B3 plus a sugar (ribose). After oral ingestion it enters the bloodstream, is transported into cells via ENT transporters, and is converted to NMN by NRK enzymes, then to NAD. It requires a phosphate group (which may be rate-limiting) to complete the conversion.

Animal Evidence

NR extended yeast lifespan by ~30% via sirtuin pathway activation. In mice, NR given late in life (equivalent to age 70 in humans) extended lifespan by ~9%, with increased mitochondria, improved athleticism, and reduced inflammation.

Human Evidence

Doses of 250 mg–1 g/day raise blood NAD levels over 9–10 days with no significant adverse effects. Reduced inflammation has been demonstrated. However, the insulin sensitivity improvements and mitochondrial benefits seen in mice have not yet been confirmed in short-term human trials. One study combining NR with pterostilbene showed functional improvement in ALS patients.

3. NMN (Nicotinamide Mononucleotide)

Mechanism. NMN is one step closer to NAD than NR (it already has the phosphate group). A specific transporter protein, SLC12A8, discovered by Shin Imai at Washington University, takes NMN directly into cells. This may explain its greater potency.

Animal Evidence

Shin Imai’s half-lifespan study showed NMN slowed aging effects in mice but was halted due to limited NMN supply. Sinclair’s lab completed a full lifespan study at 400 mg/kg showing 10–15% lifespan extension, with more pronounced effects in females. Treated mice showed less frailty, better mitochondrial function, and greater running endurance.

Human Evidence

Other labs have demonstrated NMN protects kidneys and heart from damage and enhances wound healing in animals.

Bioavailability. Oral ingestion (capsule, powder, or sublingual) raises NAD 2–3 fold. No evidence of significant advantage for sublingual over swallowed forms. Standard studied dose: 1 g/day.

Cancer Concern with NAD Boosters

Two mouse studies warrant mention. One (Wash U) showed that reducing NAD in brain tumours slowed growth—but this was misreported as “NAD causes cancer.” A second (2019) found that NMN accelerated precancerous growths in mice genetically predisposed to pancreatic cancer, possibly via P53 suppression. Importantly, normal mice given NMN showed no increased cancer risk and lived longer. Sinclair advises consulting a physician, especially for those with cancer history.

4. NAD Intravenous Therapy

Current status. NAD IV drips (typically >1 hour, administered under medical supervision) are increasingly popular for addiction recovery, depression, energy, and hangovers. NAD is too large to enter most cells directly (except neurons), so the body must break it down and re-assemble it.

Evidence level. Sinclair notes extensive anecdotal data (improved mood, energy) but no published placebo-controlled trial. He considers the anecdotal volume compelling but cannot draw conclusions without controlled data. The hangover application has plausible biochemistry: alcohol dehydrogenase requires NAD, and a hangover likely involves hepatic NAD depletion.

5. Resveratrol

Discovery. Sinclair and Conrad Howitz screened thousands of molecules for Sirt-1 activation in the early 2000s. Resveratrol, a polyphenol found in red wine grapes and polygonum cuspidatum (Japanese knotweed), activated Sirt-1 13-fold and was published in Nature (2003). Red wine sales rose 30% following publication.

Animal Evidence

Obese mice on a Western diet given resveratrol lived as long as lean controls—the first demonstration that caloric restriction could be mimicked pharmacologically. Anti-cancer activity was shown in a 1999 Science paper (topical application reduced carcinogen-induced skin tumours). Over 1,000 papers document benefits including metabolic rate, mitochondrial boosting, and glucose control.

Human Evidence

A 2019 study showed reduced fasting glucose and increased insulin sensitivity. Battista and George et al. (2020) RCT in 25 individuals (age 30–60, BMI ~30) demonstrated lower cholesterol, lower urea (kidney marker), and raised HDL. Minimum effective dose in literature: 250 mg/day; some take up to 2,000 mg/day.

6. Fisetin and Quercetin (Senolytics)

Dual function. Originally identified alongside resveratrol as sirtuin activators, both fisetin and quercetin have emerged as potent senolytics—compounds that selectively kill senescent (“zombie”) cells that accumulate with age, secrete inflammatory factors (SASP), and promote cancer.

Quercetin

Better studied as a senolytic. Jim Kirkland (Mayo Clinic) combined quercetin with dasatinib (a leukaemia drug) to create a potent senolytic cocktail. Human studies show reduced liver steatosis (fatty liver), lower inflammation, and measurable clearance of senescent cells. Dasatinib is prescription-only and available only through clinical trials for this purpose.

Fisetin

Found in strawberries, grapes, and apples. University of Minnesota studies showed fisetin extended mouse lifespan up to 30% when given young or even late in life (equivalent to age 75 in humans). Kirkland’s AFFIRM-LITE trial is testing 20 mg/kg in humans; results expected within a year. Human data is currently limited to reduced inflammation. Available over the counter, but Sinclair advises caution pending more safety data.

7. Rapamycin and Rapalogs

Mechanism. Rapamycin inhibits mTOR (Target Of Rapamycin), mimicking the effects of protein restriction and activating autophagy—the body’s cellular recycling program. Discovered on Easter Island (Rapanui) from a fungus scraped off a statue. It has extended lifespan in every organism tested: yeast, worms, flies, and mice, including when given late in life.

Limitations. Rapamycin is an immune suppressant at higher doses (used clinically for organ transplant rejection and cancer). The longevity dose (~10 mg/week in humans) is thought to be below the immunosuppressive threshold, but toxicity risk remains. It is not currently available for anti-aging use outside clinical trials.

8. Spermidine

Mechanism. Spermidine stimulates autophagy (like rapamycin via the mTOR pathway) and stabilises epigenomic changes—one of the proposed fundamental causes of aging. Sourced from wheat germ and soy products (originally crystallised from human sperm by Antony van Leeuwenhoek, hence the name).

Animal Evidence

Extended lifespan in yeast, flies, worms, and mice. In mice, both early-life and late-life administration improved heart function and extended lifespan.

Human Evidence

9. Metformin

Mechanism. Metformin activates AMPK by binding mitochondrial complex I, reducing ATP production and triggering mitohormesis (“what doesn’t kill the cell makes it stronger”). This leads to increased mitochondria, improved insulin signalling, and mTOR inhibition. It also raises NAD levels, activating sirtuins. Derived from the French lilac plant (guanidines), it has been used for type 2 diabetes since the 1950s.

Animal Evidence

Extended worm lifespan by 30–40 days. Sinclair’s collaboration with Rafael de Cabo at NIH showed healthier, longer-lived mice on Metformin, with improved muscle-fibre type switching (more athletic phenotype), more mitochondria, and less inflammation.

Human Evidence (Strongest of Any Molecule Discussed)

The TAME trial (Targeting Aging by Metformin), led by Nir Barzilai at Albert Einstein College of Medicine, is a multi-institutional study aiming to prove to the FDA that aging itself is a treatable condition. Funding has been challenging because Metformin is off-patent (pennies per dose).

Side Effects & Practical Considerations

GI upset (most common), rare lactic acidosis (potentially fatal). About 20% of people cannot tolerate it. A modest (~5%) reduction in muscle hypertrophy has been observed, but muscle strength and inflammation profiles are improved. Sinclair skips Metformin on days before heavy exercise. Available by prescription in the US, UK, Europe, and Australia; over-the-counter in many other countries. Increasingly prescribed off-label by physicians for pre-diabetic and longevity applications.

10. Berberine

The OTC Metformin alternative. Berberine is a plant alkaloid from bark and roots that binds mitochondrial complex I identically to Metformin, reducing ATP and triggering the same mitohormesis cascade: AMPK activation, increased mitochondria, improved insulin sensitivity, and lower blood glucose.

Evidence. Extended lifespan in mice (including those treated with chemotherapy) and fruit flies. Human clinical studies at 1–2 g/day confirm improved insulin sensitivity and lower blood glucose, comparable to Metformin. Poorly soluble—should be taken with food. Side effects mirror Metformin (GI disturbance) but no major safety concerns have been identified.

11. David Sinclair’s Personal Protocol

Sinclair has been taking longevity supplements since his early thirties and monitors bloodwork regularly via Inside Tracker. He emphasises this is his personal regimen—not medical advice—and that regular monitoring (especially liver function: AST/ALT) is essential.

12. The Three Longevity Pathways

Sinclair frames all longevity interventions through three interconnected survival pathways. Each molecule discussed targets one or more of these, and the pathways communicate with each other in a coordinated defence network.

Bottom Line

Lifespan Podcast — David Sinclair, PhD & Matthew LaPlante
Prepared from podcast transcript — April 2026